Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-07
DOI
10.1007/s00018-018-2960-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional selectivity of GPCR-directed drug action through location bias
- (2017) Roshanak Irannejad et al. Nature Chemical Biology
- A kinetic view of GPCR allostery and biased agonism
- (2017) J Robert Lane et al. Nature Chemical Biology
- G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning
- (2017) Lauriane Onfroy et al. Scientific Reports
- Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
- (2016) R. Aungraheeta et al. BLOOD
- Associations ofP2Y12Rgene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel
- (2016) Hong-Hui Yang et al. Cardiovascular Therapeutics
- Cardioprotective Angiotensin-(1–7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 ReceptorNovelty and Significance
- (2016) Ségolène Galandrin et al. HYPERTENSION
- Delineating biased ligand efficacy at 7TM receptors from an experimental perspective
- (2016) Ségolène Galandrin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnostics
- (2016) Martin Unverdorben et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
- (2016) Eugene R. Viscusi et al. PAIN
- Current status of data on cangrelor
- (2016) Arman Qamar et al. PHARMACOLOGY & THERAPEUTICS
- Influence of P2Y12 polymorphisms on platelet activity but not ex-vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects
- (2015) Mu-Peng Li et al. BLOOD COAGULATION & FIBRINOLYSIS
- Ticagrelor-related gout: An underestimated side effect
- (2015) Nixiao Zhang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling
- (2015) Céline M'Kadmi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pioneering biased ligand offers efficacy with reduced on-target toxicity
- (2015) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- The G protein α subunit variant XLαspromotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo
- (2015) Qing He et al. Science Signaling
- The G protein α subunit variant XLαspromotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo
- (2015) Qing He et al. Science Signaling
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A novel mutation in the P2Y12receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding
- (2014) Y. M. Patel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Agonist-bound structure of the human P2Y12 receptor
- (2014) Jin Zhang et al. NATURE
- Structure of the human P2Y12 receptor in complex with an antithrombotic drug
- (2014) Kaihua Zhang et al. NATURE
- P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting
- (2013) Naguib Zoheir et al. BLOOD COAGULATION & FIBRINOLYSIS
- Dyspnea and Reversibility of Antiplatelet Agents: Ticagrelor, Elinogrel, Cangrelor, and Beyond
- (2013) Victor L. Serebruany et al. CARDIOLOGY
- Activation of TRPC4β by Gαi subunit increases Ca2+ selectivity and controls neurite morphogenesis in cultured hippocampal neuron
- (2013) Jae-Pyo Jeon et al. CELL CALCIUM
- Role of the ubiquitin–proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake
- (2013) Véronique Pons et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
- (2013) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Constitutive -Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence
- (2013) G. Corder et al. SCIENCE
- Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population
- (2013) Kyoung-Ah Kim et al. THROMBOSIS RESEARCH
- Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands
- (2012) Colette Denis et al. CURRENT PHARMACEUTICAL DESIGN
- Deciphering biased-agonism complexity reveals a new active AT1 receptor entity
- (2012) Aude Saulière et al. Nature Chemical Biology
- An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets
- (2011) S. Nisar et al. BLOOD
- The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial
- (2011) Benjamin M. Scirica et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation
- (2011) Su-Jun Lee et al. THROMBOSIS RESEARCH
- Ticagrelor for the treatment of arterial thrombosis
- (2010) Paul A Gurbel et al. EXPERT OPINION ON PHARMACOTHERAPY
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct conformational changes in -arrestin report biased agonism at seven-transmembrane receptors
- (2008) A. K. Shukla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started